Plasmodium falciparum sporozoite and liver stage antigens

  • US Patent No. 9694062
  • Issued: July 04, 2017
  • Status: Active
Medical & Biotechnology

The invention provides novel malaria polypeptides expressed at the pre-erythrocytic stage of the malaria life-cycle. The antigens can be utilized to induce an immune response against malaria in a mammal by administering the antigens in vaccine formulations or expressing the antigens in DNA or other nucleic acid expression systems delivered as a vaccine formulation.

Do you have questions or need more information on a specific technology? Let's talk.

Contact Us